IVIG Dosing in Immune Thrombocytopenic Purpura (ITP)

Adult ITP Treatment Guidelines

The American Society of Hematology recommends a dose of 1 g/kg as a one-time dose of Intravenous Immunoglobulin (IVIG) for the treatment of Immune Thrombocytopenic Purpura (ITP), which may be repeated if necessary 1, 2
IVIG should be used when a more rapid increase in platelet count is required, often in combination with corticosteroids, as recommended by the American Society of Hematology 1, 3
The initial dose should be 1 g/kg as a one-time dose, with possible repeat treatment based on the platelet response, according to the American Society of Hematology 1, 4
The traditional regimen of 0.4 g/kg/day over 5 days has been largely replaced by the shorter 1 g/kg one-time dosing, as reported by the American Society of Hematology 4, 5

IVIG produces a more rapid platelet count increase compared to corticosteroids, with many patients responding within 24 hours, as observed by the American Society of Hematology 3, 5
Peak response typically occurs within 2-4 days, according to the American Society of Hematology 3
The effect is usually transient, with platelet counts returning to pretreatment levels within 2-4 weeks, as reported by the American Society of Hematology 3

Concomitant use of corticosteroids with IVIG may enhance the platelet response, reduce infusion reactions, and prevent aseptic meningitis, as recommended by the American Society of Hematology 5

In patients with uncontrolled bleeding or requiring urgent procedures, IVIG (1 g/kg) combined with high-dose corticosteroids is recommended by the American Society of Hematology 5
This approach provides rapid platelet count elevation, according to the American Society of Hematology 5
For life-threatening bleeding, consider adding platelet transfusions to IVIG, as suggested by the American Society of Hematology 5

IVIG (1 g/kg) is recommended for pregnant patients requiring treatment for ITP, as recommended by the American College of Obstetricians and Gynecologists 1, 6
IVIG is considered safe during pregnancy and is one of the first-line options along with corticosteroids, according to the American College of Obstetricians and Gynecologists 6

For immune checkpoint inhibitor-induced ITP with platelet counts <50 × 10⁹/L, IVIG at 1 g/kg as a one-time dose is recommended, often in conjunction with corticosteroids, as recommended by the Society for Immunotherapy of Cancer 7, 8
For severe thrombocytopenia, hematology consultation is advised by the Society for Immunotherapy of Cancer 8

Common adverse effects of IVIG include headaches, as reported by the American Society of Hematology 3, 5
Transient neutropenia is a possible adverse effect of IVIG, according to the American Society of Hematology 3
Serious but rare adverse effects of IVIG include renal insufficiency, as reported by the American Society of Hematology 3
Thrombotic events are a rare but serious adverse effect of IVIG, according to the American Society of Hematology 3, 5

Premedication with acetaminophen/paracetamol or corticosteroids may reduce infusion reactions, as recommended by the American Society of Hematology 5
IVIG is a pooled blood product, and patients should be informed of the theoretical risk of infectious disease transmission, although modern processing has minimized this risk, as reported by the American Society of Hematology 5